The Leukostrat CDx FLT3 Mutation Assay is designed to detect internal tandem duplications and tyrosine kinase mutations (TKD) in the FLT3 gene. The Leukostrat CDx FLT3 Mutation Assay is the only in vitro diagnostic assay authorized by the FDA for AML patients.
Additional Test Information
Na Heparin Whole Blood, Na Heparin Bone Marrow, EDTA Whole Blood, EDTA Bone Marrow
Additional Sample Requirements
Specimens can be stored at 2-8 C for up to 7 days prior to testing. Do not freeze. Frozen samples are not acceptable.
2 ml Na Heparin Whole Blood or 0.5 ml Na Heparin Bone Marrow
1 ml Na Heparin Whole Blood or 0.25 ml Na Heparin Bone Marrow
PCR and Capillary Electrophoresis